Nyarko v. Davita Kidney Care

CourtDistrict Court, D. Maryland
DecidedMarch 31, 2023
Docket8:22-cv-01141
StatusUnknown

This text of Nyarko v. Davita Kidney Care (Nyarko v. Davita Kidney Care) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nyarko v. Davita Kidney Care, (D. Md. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

MICHELLE NYARKO, *

Plaintiff, *

v. * Civ. No. DLB-22-1141

DAVITA KIDNEY CARE, et al., *

Defendants. *

MEMORANDUM OPINION Self-represented plaintiff Michelle Nyarko filed a complaint against her employer, DaVita Kidney Care (“DaVita”),1 and John Does 1 through 10, alleging disability discrimination, failure to accommodate, and retaliation in violation of the Americans with Disabilities Act of 1990 (“ADA”), 42 U.S.C. § 12101 et seq. ECF 1. DaVita has moved to dismiss Nyarko’s complaint under Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim. ECF 10. Nyarko has opposed the motion, ECF 14, and DaVita filed a reply, ECF 15. Nyarko moved for leave to file a surreply. ECF 16.2 No hearing is necessary. See Loc. R. 105.6 (D. Md. 2021). For the reasons stated below, the motion to dismiss is granted.

1 The defendant states that the plaintiff incorrectly identified it as DaVita Kidney Care and that its correct name is Total Renal Care, Inc. ECF 10, at 1. Because the defendant refers to itself as “DaVita,” the Court will too.

2 “Unless ordered by the Court, surreply memoranda are not permitted to be filed.” Loc. R. 105.2(a) (D. Md. 2021). A surreply, though “highly disfavored in this District,” Medish v. Johns Hopkins Health Sys. Corp., 272 F. Supp. 3d 719, 722 (D. Md. 2017) (citation omitted), is permitted when the opposing party raises an issue in its reply for the first time, such that the moving party would be unable to contest the matter without filing a surreply, see Lewis v. Rumsfeld, 154 F. Supp. 2d 56, 61 (D.D.C. 2001). Nyarko claims that DaVita raised arguments about pay raises in its reply to which she needed to respond. ECF 16, at 1. Her motion for leave to file a surreply is granted, and the Court has considered her surreply. I. Background The Court accepts as true the following facts alleged in Nyarko’s complaint and the exhibits attached to her complaint. See Aziz v. Alcolac, Inc., 658 F.3d 388, 390 (4th Cir. 2011). When the allegations in the complaint conflict with an exhibit, “the exhibit prevails.” Fayetteville Invs. v. Com. Builders, Inc., 936 F.2d 1462, 1465 (4th Cir. 1991). The Court summarizes Nyarko’s

primary allegations in this section and will supplement its analysis of her claims with additional allegations as appropriate. Nyarko began working for DaVita, a provider of outpatient kidney dialysis services, as a social worker on May 26, 2020. ECF 1, ¶ 15. She alleges that before she was hired, she expressed her need for maintaining a stable work environment and her concerns about COVID-19. Id. She was informed that she would be working in two locations, Calverton and Glenarden. Id.; see also ECF 1-3, at 4; ECF 1-5, at 2. The Glenarden site was “exclusively treating COVID-19 patients from the regional cohort.” ECF 1, ¶ 15. At the Glenarden site, Nyarko “was responsible for servicing the otherwise virus-free [Glenarden] patients.” Id. On June 11, 2020, she was informed that she would be transferred to the Mt. Rainier

location.3 ECF 1, at ¶¶ 15–16. DaVita’s regional director told Nyarko the transfer “was a ‘operational decision’ based upon [her] communicated concerns about contracting COVID-19.” ECF 1-5, at 3. After Nyarko learned of the upcoming transfer, her training was paused and her contact with patients was limited, disrupting the stability of her work environment. ECF 1, ¶¶ 15– 16. This triggered her anxiety, and on June 15, 2020, she requested an accommodation by email.

3 In her complaint, Nyarko alleges that she was informed of the transfer on June 12, 2020, but a June 12 email attached to her complaint states: “[Y]esterday I was told otherwise. I was informed, I was to be transferred to Mt. Rainer [sic] site.” ECF 1-4, at 2. Another attached email states, “[O]n June 11, 2020, I was unilaterally advised . . . of my scheduled switch of my secondary from the Glenarden site to the Mt. Rainer [sic] site.” ECF 1-5, at 2–3. Id. ¶¶ 16–17; ECF 1-5, at 1, 4. In her email, which is not attached to her complaint, she “made [DaVita] aware of the full extent of [her] disability[.]” ECF 1, ¶ 17. DaVita followed up with Nyarko’s treating physician on June 17, 2020, requesting more information. ECF 1-5, at 6. On June 24, 2020, Nyarko’s work site was officially changed, which she alleges resulted in an increase in caseload and the necessity to work with two different supervisors. ECF 1, ¶ 18.

Nyarko’s physician completed the accommodation paperwork on June 26, 2020. ECF 1- 5, at 6–7. Her physician reported that Nyarko had a permanent disability, “anxiety/depression and PTSD,” and that Nyarko could not perform the essential functions of her position, namely “focusing and concentrating on work tasks to support patients.” Id. at 6. As an accommodation, Nyarko’s physician suggested that Nyarko be given “advance notice of work changes + new assignments, open communication with her team with possible written communication, ongoing access to needed equipment/supplies to perform needed duties.” Id. at 7. Her physician added: “Due to underlying health issues, should not work at an identified COVID-19 site.” Id. In a subsequent, undated letter, Nyarko confirmed her requested accommodations:

(1) A transition plan; (2) Advanced notice of upcoming work changes and new assignments; (3) Improved communication, including involvement with the decision-making process for items such as scheduling as example, and written notices for items of important [sic] that may have before only been verbally set forth; (4) Consistent and continued access to equipment and resources required to carry out my duties; and (5) Improved transparency.

Id. at 4. Nyarko alleges that her requests for reasonable accommodation were denied on July 10, 2020 “in a stigmatizing and dismissive response letter.” ECF 1, ¶ 20; see also ECF 1-5, at 8 (the letter). The letter stated that DaVita would provide advance notice of work changes and new assignments and would encourage open communication with teammates, as Nyarko had requested. ECF 1-5, at 8. It also stated, “DaVita ensures that all teammates have access to equipment/supplies to safely deliver patient care.” Id. Finally, the letter confirmed that Nyarko was not assigned to a COVID-19 “cohort” facility and outlined the DaVita’s processes for compliance with CDC guidelines and safety and infection protocols, although it noted that DaVita is “unable to ensure that teammate’s [sic] are not working in a site that may have COVID patients.” Id. Nyarko responded by letter through legal counsel on July 20, 2020, offering to settle for

$90,000 her potential legal claims against DaVita for discrimination and failure to accommodate her disabilities. ECF 1-5, at 13–14. She believes she had the highest caseload in the cohort, worked out of two-and-a-half locations, and a co-worker that replaced her at the Glenarden site was provided a COVID-19-related accommodation. ECF 1, ¶ 20. She also believes that DaVita had previously agreed to a reasonable accommodation that she would not work in a COVID-19 location but then “reneged on this promise.” Id. ¶¶ 25, 28. Nyarko made another accommodation request on February 4, 2021. ECF 1-5, at 36–38. She requested that her time for screening patients be limited to 30 minutes a day due to her pre- existing conditions that placed her at higher risk during the COVID-19 pandemic. Id. On February

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Harrington v. Harris
118 F.3d 359 (Fifth Circuit, 1997)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
Oncale v. Sundowner Offshore Services, Inc.
523 U.S. 75 (Supreme Court, 1998)
Burlington Industries, Inc. v. Ellerth
524 U.S. 742 (Supreme Court, 1998)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Tennessee v. Lane
541 U.S. 509 (Supreme Court, 2004)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Jones v. Sternheimer
387 F. App'x 366 (Fourth Circuit, 2010)
Schneider v. Giant of Maryland, LLC
389 F. App'x 263 (Fourth Circuit, 2010)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Hoyle v. FREIGHTLINER, LLC
650 F.3d 321 (Fourth Circuit, 2011)
Aziz v. Alcolac, Inc.
658 F.3d 388 (Fourth Circuit, 2011)
Baird v. Rose
192 F.3d 462 (Fourth Circuit, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
Nyarko v. Davita Kidney Care, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nyarko-v-davita-kidney-care-mdd-2023.